Home LiteratureArticle Details
PMID: 28094055 Published · ppublish English Journal Article

Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.

European urology ·Vol. 72 ·No. 2 ·2017-00-00 ·Pages 300-306

Gershman B, Moreira DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC

Abstract

Renal cell carcinoma (RCC) with isolated lymph node (LN) involvement has historically been associated with poor prognosis. However, a subset of patients may experience long-term survival. To examine the natural history of RCC with isolated LN involvement following surgical resection with long-term follow-up, and to evaluate clinicopathologic features associated with disease progression and survival. A total of 138 patients with isolated pN1M0 RCC underwent partial or radical nephrectomy and LN dissection from 1980 to 2010. Partial or radical nephrectomy with LN dissection. Metastasis-free survival (MFS), cancer-specific survival (CSS), and overall survival (OS) were estimated using the Kaplan-Meier method. Associations between clinicopathologic features and oncologic outcomes were evaluated using Cox regression models. Median follow-up among survivors was 8.5 yr. The 5-yr and 10-yr MFS, CSS, and OS rates were 16% and 15%, 26% and 21%, and 25% and 15%, respectively. The median time to development of metastases was only 4.2 mo. On multivariable analysis, symptoms at presentation (hazard ratio [HR] 2.40; p=0.03), inferior vena cava tumor thrombus (HR 1.99; p=0.003), clear cell (HR 2.21; p=0.01) and collecting duct/not otherwise specified (HR 4.28; p<0.001) histologic subtypes, pT4 stage (HR 2.64; p=0.005), and coagulative tumor necrosis (HR 2.51; p<0.001) were independently associated with development of metastases. MFS rates at 1 yr after surgery were 71%, 63%, 33%, and 7% for patients with one, two, three, and four to five adverse features, respectively. Limitations include surgical selection bias. Although isolated pN1 disease portends a poor prognosis, a small subset of patients experience durable long-term survival after surgical resection of isolated lymphatic metastases. Adverse prognostic features may enhance patient risk stratification and facilitate multimodal management approaches. Although isolated lymph node metastases portend a poor prognosis, a small subset of patients experience long-term survival following surgical resection.

Keywords
Lymph nodes Natural history Nephrectomy Renal cell carcinoma Survival
MeSH Terms
Aged Carcinoma, Renal Cell/mortality,secondary,surgery Disease Progression Disease-Free Survival Female Humans Kaplan-Meier Estimate Kidney Neoplasms/mortality,pathology,surgery Lymph Node Excision/adverse effects,mortality Lymphatic Metastasis Male Middle Aged Multivariate Analysis Neoplasm Staging Nephrectomy/adverse effects,mortality Proportional Hazards Models Retrospective Studies Risk Factors Time Factors Treatment Outcome
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Gershman Boris
Division of Urology, Rhode Island Hospital and The Miriam Hospital, Providence, RI, USA.
Moreira Daniel M
Department of Urology, University of Illinois, Chicago, IL, USA.
Thompson R Houston
Department of Urology, Mayo Clinic, Rochester, MN, USA.
Boorjian Stephen A
Department of Urology, Mayo Clinic, Rochester, MN, USA.
Lohse Christine M
Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Costello Brian A
Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Cheville John C
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Leibovich Bradley C
Department of Urology, Mayo Clinic, Rochester, MN, USA. Electronic address: leibovich.bradley@mayo.edu.
Article Info
Journal
European urology
Abbr.
Eur Urol
ISSN
1873-7560
Published
2017-00-00
Epub
2017-00-13
Pages
300-306
Language
English
Region
Switzerland
NLM ID
7512719
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com